Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit
Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminde...
Saved in:
Main Authors: | Fatemeh Mohaghegh, Parvaneh Hatami, Zeinab Aryanian, Farahnaz Fatemi, Zeinab Mohseni Afshar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/9880827 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute generalized exanthematous pustulosis induced by sulfasalazine: Uncommon presentation of a common culprit
by: Deepak Vashisht, et al.
Published: (2022-01-01) -
Five-Year Retrospective Review of Acute Generalized Exanthematous Pustulosis
by: Chitprapassorn Thienvibul, et al.
Published: (2015-01-01) -
Acute generalized exanthematous pustulosis induced by ceftriaxone with positive patch testing
by: Ana Gabriela Lopes, et al.
Published: (2024-02-01) -
Single-cell immunopathology of recurrent acute generalized exanthematous pustulosis associated with vancomycin
by: Eric M. Mukherjee, MD, PhD, et al.
Published: (2025-05-01) -
Acute Generalized Exanthematous Pustulosis Induced by Etanercept: Another Dermatologic Adverse Effect
by: Mukaddes Kavala, et al.
Published: (2013-01-01)